KIF11 and pachyonychia congenita: Pudova and colleagues found a strong negative correlation between KIF11 expression and tumor progression-free survival, thus confirming the fact that an Eg5 expression leads to worse PC prognosis for patients compared to those with lower levels of Eg5 [55].